A method to prevent graft rejection using tgf-beta to induce t suppressor cells

Details for Australian Patent Application No. 2001253400 (hide)

Owner University of Southern California

Inventors Horwitz, David

Agent Freehills

Pub. Number AU-B-2001253400

PCT Pub. Number WO01/77299

Priority 60196446 11.04.00 US

Filing date 11 April 2001

Wipo publication date 23 October 2001

Acceptance publication date 1 March 2007

International Classifications

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

1 March 2007 Application Accepted

  Published as AU-B-2001253400

28 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253401-Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality

2001253399